Screener
Edwards Lifesciences EW Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
FAQ
- What is Edwards Lifesciences's free cash flow?
- Edwards Lifesciences (EW) reported free cash flow of -$21.1M in Q1 2026.
- How has Edwards Lifesciences's free cash flow changed year-over-year?
- Edwards Lifesciences's free cash flow decreased by 109.4% year-over-year, from $224.4M to -$21.1M.
- What is the long-term trend for Edwards Lifesciences's free cash flow?
- Over 3 years (2021 to 2025), Edwards Lifesciences's free cash flow has grown at a -1.7% compound annual growth rate (CAGR), from $1.41B to $1.34B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Edwards Lifesciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude